Prof. Dr. Duygu Derin

Prof. Dr. Duygu Derin
Academic Title :
Prof. Dr.

Prof. Dr. Duygu Derin is an eminent specialist in medical oncology practicing in the Department of Oncology at Liv Hospital Ulus in Istanbul. She possesses an extensive clinical experience of over 25 years, specializing in the diagnosis and treatment of various malignant diseases such as breast, lung, colon, and gynecological cancers.

Education and Academic Qualifications

  • Graduate of Galatasaray Lycée, 1987
  • Doctor of Medicine (MD) from Istanbul University, Istanbul Faculty of Medicine, 1993
  • Specialization in Internal Medicine from Taksim Training and Research Hospital, 2001
  • Fellowship in Medical Oncology from Istanbul University Oncology Institute, 2006
  • Earned the title of Associate Professor of Medical Oncology, April 2010
  • Earned the title of Professor of Medical Oncology, April 2016

Areas of Interest

  • Breast cancer
  • Lung cancer
  • Colon and colorectal cancer
  • Gynecological cancers (ovarian and uterine cancers)
  • Gastrointestinal tumors (stomach, liver, and pancreatic cancers)
  • Chemotherapy, immunotherapy, and targeted therapies for cancer
  • Medical Oncology Specialist at Liv Hospital Ulus in Istanbul (2016 - Present)
  • Medical Oncology Specialist at NeoLife Medical Center (2010 - 2016)
  • Medical Oncology Specialist at American Hospital Istanbul (2009 - 2010)
  • Mandatory Service as Oncology Specialist at Kayseri Training and Research Hospital (2006 - 2008)
  • Turkish Medical Oncology Society
  • Turkish Medical Association
  • Turkish Association for Lung Cancer
  • Galatasaray Lycée Alumni Association
  • Utility of serum and urine uPAR levels for diagnosis of breast cancer, Asian Pacific Journal of Cancer Prevention, 2012
  • Serum levels of apoptosis biomarkers, survivin and TNF-alpha in non-small cell lung cancer, Lung Cancer, 2008
  • Effect of kefir on the quality of life of patients being treated for colorectal cancer, Oncology Nursing Forum, 2009
  • Serum and urine survivin levels in breast cancer, Medical Oncology, 2006
Share :